Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-14-023013)

Filing Details

Accession Number:: 0001225208-14-023013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-10 17:34:19
Reporting Period:: 2014-11-07

Filing Date:: 2014-11-10
Accepted Time:: 2014-11-10 17:34:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551792	D John Young	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Group President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-07	21,600	$26.20	123,462	No	4	M	Direct
Common Stock	Disposition	2014-11-07	7,644	$29.88	115,818	No	4	S	Direct
Common Stock	Disposition	2014-11-07	13,956	$29.89	101,862	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-11-07	21,600	$0.00	21,600	$26.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2015-02-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,075	Indirect	By Rule 16b-3 Plan
Common Stock	1,294	Indirect	By Trustee under the Pfizer Share Ownership Plan

Footnotes

These options are fully exercisable.